Related Experiment Videos
Testicular seminoma and Down's syndrome
D Roberge1, L Souhami, M Laplante
1Department of Oncology (Division of Radiation Oncology) McGill University, Montreal, Quebec, Canada.
The Canadian Journal of Urology
|March 27, 2001
Summary
Testicular seminoma is associated with Down's syndrome (DS), with most cases diagnosed at Stage I. Standard therapies are effective for DS patients with testicular cancer, even with decreased life expectancy.
Area of Science:
- Oncology
- Genetics
- Pediatrics
Background:
- Down's syndrome (DS) is a genetic disorder associated with an increased risk of certain cancers.
- Testicular seminoma is a type of germ cell tumor that affects the testes.
Observation:
- A review of 19 cases of testicular seminoma in patients with Down's syndrome was conducted.
- The mean age at diagnosis was 32 years, with 73% of cases presenting at Stage I.
- The oldest reported patient was 47 years old, suggesting a potential skew in age distribution due to decreased life expectancy in DS.
Findings:
- There is a documented association between Down's syndrome and testicular seminoma.
- Possible contributing factors include increased rates of cryptorchidism, elevated gonadotropin levels, and genetic instability.
- Stage at presentation in DS patients is comparable to the general population.
Implications:
- Increased life expectancy in Down's syndrome patients may lead to a higher incidence of testicular seminoma being diagnosed in the future.
- Standard therapeutic approaches for testicular seminoma appear effective in patients with Down's syndrome.
- Further research into the underlying mechanisms and surveillance strategies is warranted.